PUMA BIOTECHNOLOGY INC
PBYINASDAQ🏆 #2814 by market capEarnings Nov 5 · PostUS Equity
$10.54▼ $0.09 (−0.89%)
🌅 Pre-market$10.54▲ 0.05%Regular close · extended-hours price shownTrack PBYI
Get earnings, price moves & breaking news on Telegram
24h▼ 0.9%
7d▼ 4.6%
14d▲ 7.2%
30d▲ 6.0%
ytd▲ 77.1%
1y▲ 92.9%
🏦Market Cap
$544M
Small Cap
📈Revenue Growth (YoY)
-2.9%
Declining
📊Gross Margin
74.8%
High
💵FCF Margin
17.8%
Healthy
⚖️P/S Ratio
2.4x
Cheap
Otter Score
—
Insufficient data
PUMA BIOTECHNOLOGY INC
PBYIAnalyst Ratings
Price
$10.54
Total
20
Raised
1
Lowered
3
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
TD Cowen | Reiterated | Hold | 2026-08-07 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2025-02-28 | — | — |
Citigroup | Upgraded | Neutral → Buy | 2021-09-28 | — | — |
RBC Capital | Reiterated | Sector Perform | 2021-08-06 | — | — |
Goldman Sachs | Reiterated | Sell | 2021-08-06 | — | — |
SVB Leerink | Reiterated | Market Perform | 2020-08-07 | — | — |
B of A Securities | Reiterated | Underperform | 2020-06-25 | — | — |
Cantor Fitzgerald | Reiterated | Neutral | 2020-05-20 | — | — |
H.C. Wainwright | Reiterated | Buy | 2019-12-06 | — | — |
Barclays | Reiterated | Underweight | 2019-08-09 | — | — |
Citi | Downgraded | Buy → Neutral | 2019-05-10 | — | — |
Leerink Swann | Reiterated | Market Perform → Perform | 2019-01-17 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2019-01-03 | — | — |
JP Morgan | Reiterated | Underweight | 2018-11-02 | — | — |
Stifel | Reiterated | Buy | 2018-03-09 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2018-03-09 | — | — |
Bank of America | Reiterated | Buy | 2018-01-24 | — | — |
Credit Suisse | Reiterated | Outperform | 2018-01-24 | — | — |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2018-01-24 | — | — |
UBS | Reiterated | Buy | 2016-04-11 | — | — |
Institution
TD Cowen
Reiterated · Hold · 2026-08-07
—
—
HC Wainwright & Co.
Reiterated · Buy · 2025-02-28
—
—
Citigroup
Upgraded · Neutral → Buy · 2021-09-28
—
—
RBC Capital
Reiterated · Sector Perform · 2021-08-06
—
—
Goldman Sachs
Reiterated · Sell · 2021-08-06
—
—
SVB Leerink
Reiterated · Market Perform · 2020-08-07
—
—
B of A Securities
Reiterated · Underperform · 2020-06-25
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2020-05-20
—
—
H.C. Wainwright
Reiterated · Buy · 2019-12-06
—
—
Barclays
Reiterated · Underweight · 2019-08-09
—
—
Citi
Downgraded · Buy → Neutral · 2019-05-10
—
—
Leerink Swann
Reiterated · Market Perform → Perform · 2019-01-17
—
—
Guggenheim
Downgraded · Buy → Neutral · 2019-01-03
—
—
JP Morgan
Reiterated · Underweight · 2018-11-02
—
—
Stifel
Reiterated · Buy · 2018-03-09
—
—
Stifel Nicolaus
Reiterated · Buy · 2018-03-09
—
—
Bank of America
Reiterated · Buy · 2018-01-24
—
—
Credit Suisse
Reiterated · Outperform · 2018-01-24
—
—
Cowen & Co.
Downgraded · Outperform → Market Perform · 2018-01-24
—
—
UBS
Reiterated · Buy · 2016-04-11
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space